KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Assets Average (2016 - 2025)

Historic Assets Average for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $1.4 billion.

  • Neogenomics' Assets Average fell 1660.61% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year decrease of 1660.61%. This contributed to the annual value of $1.5 billion for FY2025, which is 968.28% down from last year.
  • Neogenomics' Assets Average amounted to $1.4 billion in Q4 2025, which was down 1660.61% from $1.4 billion recorded in Q3 2025.
  • Neogenomics' 5-year Assets Average high stood at $1.9 billion for Q3 2021, and its period low was $762.0 million during Q1 2021.
  • For the 5-year period, Neogenomics' Assets Average averaged around $1.6 billion, with its median value being $1.7 billion (2023).
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 28180.57% in 2021, then crashed by 1660.61% in 2025.
  • Neogenomics' Assets Average (Quarter) stood at $1.9 billion in 2021, then dropped by 7.43% to $1.7 billion in 2022, then fell by 3.89% to $1.7 billion in 2023, then dropped by 2.39% to $1.6 billion in 2024, then fell by 16.61% to $1.4 billion in 2025.
  • Its Assets Average was $1.4 billion in Q4 2025, compared to $1.4 billion in Q3 2025 and $1.5 billion in Q2 2025.